| |
|
|
|
Aerpio Pharmaceuticals Inc.  
|
|
1.01 -0.03 (-0.03%) |
05-17 16:00 |
|
Open: |
1.04 |
Pre close: |
1.04 |
Target:
|
1.26
|
|
High: |
1.0467 |
Low: |
0.9911 |
Resistance:
|
1.08
1.16
|
|
Volume: |
114,032 |
Market Cap: |
41M |
Support:
|
0.95
0.79
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.03
 |
MACD |
MACD(12,26):
|
-0.08  |
|
MA(20): |
1.04 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
2.18 |
Stochastic Oscillator |
%K(14,3):
|
38.10 |
|
MA(250): |
2.77 |
%D(3): |
41.80 |
|
Average Volume(K) |
3-Month: |
61456
|
52-Week |
High:
|
4.95 |
|
10-Days: |
12694 |
Low: |
0.88 |
|
RSI |
RSI(14):
|
36.88 |
Change(%): |
-75.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.420 |
Return on Equity (ttm) |
-27.6 |
Shares Out. (M) |
40.59 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-24.7 |
Shares Float (M) |
39.83 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
29.20 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.710 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.40 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.42 |
|
Profit Margin |
-17.25 |
Operating Cash Flow
(M) |
0.00 |
P/S |
75918328.00 |
|
Operating Margin |
-62.24 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
